Hematological / BMT Center
Learn More About The Hematological Oncology Program At Midwestern: Chat with Us | Email Us
Hematological Oncology at Midwestern Regional Medical Center utilizes high-powered chemotherapies and radiotherapies, alone, or in concert with pioneering immunotherapies, to deliver advanced cancer care to patients fighting hematologic malignancies. Providing both Allogeneic and Autologous Bone Marrow Transplants (BMT) / Peripheral Blood Stem Cell Transplants (PBSCT), Midwestern’s Hematologic Oncology Department delivers a comprehensive array of cutting-edge immunotherapy treatment options for patients. Spearheading the expansion into immunotherapy is CTCA partner and world-renowned Hematologic Oncologist, Dr. Shimon Slavin. Together, Dr. Slavin and Midwestern’s Hematologic Oncology Department are working to share common protocols that are changing the face of cancer treatment.